Introduction
It has been well documented that medicinal plants confer considerable anticancer activity against various tumours (Dai and Mumper, 2010) . Plants contain abundant compounds which have consistently been shown to be associated with a lower risk of cancers at almost every site, such as lung, colon, rectum, prostate, cervix, stomach, pancreas, breast, and bladder (Steinmetz and Potter, 1991) . Efforts, therefore, are being made to identify naturally occurring anticarcinogens which would prevent, slow, and/or reverse the cancer induction and its subsequent development (Chuang et al., 2000) . Inula helenium is an important herb traditionally used in the treatment of infl uenza, fever, tuberculotic enterorrhea, and chronic enterogastritis in China, Japan, and Europe (Okuda, 1986; Olechnowicz-Stepien and Skurska, 1960) . Plants of the genus Inula have been shown to contain high levels of sesquiterpene lactones (Zhao et al., 2006; Trendafi lova et al., 2010) , which recently have received considerable attention in the pharmacological community due to their antineoplastic and anti-infl ammatory effects (Konishi et al., 2002; Won et al., 2004) . Many studies indicated that sesquiterpene lactones exhibit antitumour activities in a variety of malignant cells (Ghantous et al., 2010; Chen et al., 2007) . In the present study, we investigated the antiproliferative activity of eight sesquiterpene lactones from I. helenium and I. japonica against gynecologic cancer cell lines in vitro. We also explored the antitumour activity against ascite tumour S180 xenografts in mice in vivo.
Results

Isolation of sesquiterpene lactones
The dichloromethane extract of the roots of I. helenium contained 3β,9β-diacetoxy-1β,10α-epoxy-11α,13-dihydrocostunolide (1) (Milosavljevic et al., Hatam et al., 1992) , 3β,9β-diacetoxy-11α,13-dihydrocostunolide (2) (Hatam et al., 1992) , isoalantolactone (3) (Konishi et al., 2002; Yang et al., 2003) , alantolactone (Konishi et al., 2002) , 2α-hydroxy-11α,13-dihydroisoalantolactone (4) (Topçu et al., 1993) , 11α,13-dihydroisoalantolactone (5) (Konishi et al., 2002; Yang et al., 2003) , and santamarine (6) (Romo de Vivar and Jiménez, 1965) (Fig. 1) , while britannilactone (7) (Zhou et al., 1993; Jeske et al., 1993) and 1-O-acetylbritannilactone (8) (Zhou et al., 1993; Jeske et al., 1993; Je et al., 2004) were isolated from the ethanol extract of the fl owers of I. japonica. The spectroscopic data of these compounds were in accord with those in the literature.
Antitumour Activities of Sesquiterpene Lactones from
Inhibition of growth of HeLa and A549 cells
The cytotoxic effect of compounds 1 -8 (100 μM) on the gynecologic HeLa cancer cell line was investigated. The MTT (methylthiazolyl tetrazolium) assay revealed that cisplatin, isoalantolactone (3), and santamarine (6) had a strong dose-dependent antiproliferative effect on HeLa cells; the percentages of growth inhibition by these compounds were 66%, 81%, and 86% , respectively, while the other compounds inhibited growth only weakly (Fig. 2) 
Inhibition of growth of HEC-1, SHIN3, HOC-21, and HAC-2 cells
The MTT assay revealed that cisplatin exhibited the strongest antiproliferative activity against HAC-2 cells (IC 50 = 8.95 μM) but did not inhibit the proliferation of HEC-1, SHIN3, and HOC-21 cells, respectively (Table I ). Isoalantolactone (3) was strongly antiproliferative against HEC-1, HOC-21, and HAC-2, but not against SHIN3 cells, while the other compounds did not affect growth.
Inhibition of growth of human embryonic lung fi broblast (HELF) cells
Cisplatin exhibited stronger antiproliferative activity against HELF cells (IC 50 = 16.89 μM) than isoalantolactone (3) and santamarine (6). The percentage of growth inhibition of isoalantolactone and santamarine at 100 μM on HELF cells was 47% and 22%, respectively (Fig. 3) .
Effect of isoalantolactone (3) on ascites tumours
Cyclophosphamide (cytoxan) and 3 had comparable antitumour growth activities in vivo. Inhibition (see legend to Fig. 2 ) by 3 at 100 and 10 mg/(kg d) was 64.2% and 43.0%, respectively Fig. 1 . Chemical structures of sesquiterpene lactones isolated from Inula sp.: 3β,9β-diacetoxy-1β,10α-epoxy-11α,13-dihydrocostunolide (1), 3β,9β-diacetoxy-11α,13-dihydrocostunolide (2), isoalantolactone (3), 2α-hydroxy-11α,13-dihydroisoalantolactone (4), 11α,13-dihydroisoalantolactone (5), santamarine (6), britannilactone (7), and 1-Oacetylbritannilactone (8). (Fig. 4A) .The thymus and spleen index, respectively, decreased signifi cantly in the cyclophosphamide group but they were invariable in 3 (Fig. 4B) . Furthermore, the data suggested that 3 inhibited tumour growth in vivo in a dose-dependent manner.
Discussion
Traditionally, many plants containing high levels of sesquiterpene lactones have been used as folk medicines because of their pharmacological properties. Inula species, rich in sesquiterpene lactones, have been widely used as herbal medicines in China, Japan, and Europe to treat a number of diseases, and their pharmacological activities have been confi rmed (O'Shea et al., 2009; Cantrell et al., 1999) . Some pure compounds have been isolated from I. helenium and I. japonica to prove their anticancer activity (Konishi et al., 2002; Dorn et al., 2006) . In our research, the antitumour activities of eight sesquiterpene lactones, 1 -8, extracted from I. helenium and I. japonica were explored. Our data showed that isoalantolactone (3) and santamarine (6) signifi cantly inhibited the growth of the human gynecologic cancer cell lines HeLa, HEC-1, SHIN3, HOC-21, and HAC-2, but were not cytotoxic to human embryonic lung fi broblast cells (HELF), while compounds 1, 2, 4, 5, 7, and 8 were only weakly growth inhibitory in all cell lines. Furthermore, 3 exhibited in vivo antigrowth Cisplatin >100 >100 >100 8.95 3b,9b-Diacetoxy-1b,10α-epoxy-11α,13-dihydrocostunolide (1) >100 >100 >100 >100 3b,9b-Diacetoxy-11α,13-dihydrocostunolide (2) >100 >100 >100 >100 Isoalantolactone (3) 32.54 >100 19.65 11.53 2α-Hydroxy-11α,13-dihydroisoalantolactone (4) >100 >100 >100 >100 11α,13-Dihydroisoalantolactone (5) >100 >100 >100 >100 Santamarine (6) >100 12.42 42.62 >100 Britannilactone (7) >100 >100 >100 >100 1-O-Acetylbritannilactone (8) >100 >100 >100 >100 Fig. 2 . The effect of the sesquiterpene lactones 1 to 8 on the proliferation of the HeLa tumour cell line. The percentage of growth inhibition by the compounds was calculated by comparing viable cells in the treated group with those in the untreated group. * P < 0.05, ** P < 0.01 vs. control. Fig. 3 . The effect of cisplatin, isoalantolactone (3), and santamarine (6) on the proliferation of the HELF cell line. * P < 0.05, ** P < 0.01 vs. control.
activity against ascites tumours in a dose-dependent manner. Of the eight sesquiterpene lactones isolated from Inula species, 1 and 2 belong to germacrane sesquiterpenes with a 10-membered ring, 3 -6 belong to eudesmane sesquiterpenes with a transdecalin (6/6-membered) ring, while 7 and 8 are britannilane sesquiterpenes with a 6-membered ring. Among the four eudesmanes, the exomethylene group at the γ-lactone ring of 3 and 6 is saturated in 4 and 5.
The experimental results indicate that the antigrowth activities against the human lung tumour cell lines are closely related to the carbon skeletons and the α-exomethylene group at the γ-lactone ring. Saturation of this α-exomethylene group or cleavage of the 6/6-membered ring leads to the loss or decrease of the antigrowth activity. This is in good agreement with Konishi's results where the antitumour activity of alantolactone derivatives signifi cantly decreased with C11,13-saturation (Konishi et al., 2002) .
In summary, isoalantolactone (3) and santamarine (6), two sesquiterpene lactones isolated from Inula helenium, showed potent anticancer activities against various human lung cancer cells in vitro and xenograft ascites tumours in vivo. These fi ndings indicate that 3 and 6 have signifi cant therapeutic potential and might serve as powerful novel antitumour lead compounds.
Experimental
Material
The roots of Inula helenium (3 kg dry weight) and dried fl owers of I. japonica (10 kg) were purchased at the Anguo medicinal herbs market, Hebei province, China, in April 2008. Male Kunming mice (10-week-old, 18 -22 g) were purchased from the Hebei Medical University, Hebei, China, 
Extraction of sesquiterpene lactones and structure determination
The dichloromethane extract of the roots of Inula helenium was applied to a silica gel column eluted with CH 2 Cl 2 /acetone step gradients (30:1 to 1:1) to yield 78 major fractions designated Fr DA-1 to Fr . Fr DA-1 -Fr DA-5 were submitted to preparative TLC [petroleum ether/Me 2 CO (3:1, v/v)] to isolate compounds 1 -6 and alantolactone. The dichloromethane-soluble fraction of the 95% ethanol extract of the fl owers of Inula japonica was applied to silica gel column chromatography successively for preliminary fractionation, and elution was monitored by TLC. Similar fractions were combined into several sub-fractions, which were subjected to silica gel column chromato graphy, Sephadex LH-20 gel column chromato graphy, and preparative TLC for further separation and purifi cation to obtain the pure compounds 7 and 8. The structures of these compounds were established on the basis of 1D NMR and 2D NMR analyses and comparison with data of authentic samples.
Growth inhibition assay
The human gynecologic cancer cell lines HeLa, HEC-1, SHIN3, HOC-21, HAC-2, and HELF cells were cultured in RPMI 1640 medium (Applichem, Darmstadt, Germany) containing 10% fetal bovine serum (FBS; Cellgro, Manassas, VA, USA), penicillin (100 U/ml), and streptomycin (100 μg/ml) in a humidifi ed atmosphere with 5% CO 2 at 37 °C. The viability of cells treated with various chemicals was determined by the MTT reduction assay performed in triplicate. Cells (10 4 ) were incubated in 100 μl culture medium/ well in 96-well plates for 12 h. Then the culture medium was exchanged by fresh medium containing various concentrations of the compounds (1 μM, 10 μM, 100 μM) with the positive control group containing cisplatin (Sigma Chemical Co.). After treatment with the compounds for 48 h, 10 μl of 5 mg/ml MTT was added into each well, respectively, for another 4 h. Finally, 150 μl of stop solution [10 ml of 10% sodium dodecylsulfate (SDS), 6 μl of 12 M HCl] were added into each well, and the plate was placed in an incubator with 5% CO 2 at 37 °C for 12 h. Absorbance at 570 nm was measured with a microplate reader using wells without cells as blanks (reference wavelength 490 nm). Cell survival was calculated from the absorbance and presented as percentage of the surviving cells. The growth inhibition was calculated using the following formula: growth inhibition (%) = (1 -T/C) · 100%, where T and C are the mean absorbance values of the treated and control groups, respectively.
Effects of isoalantolactone (3) on ascites tumours
Ascite tumour cells (S180) aspirated from the peritoneal cavity of mice were washed with saline, and 10 7 tumour cells were implanted into the right mediodorsal fl ask. One day later, animals were divided into fi ve groups (ten mice per group). Animals in group I were kept with water (0.02 ml/g); animals in group II received intraperitoneal administration of cyclophosphamide [Sigma; C0768; 30 mg/(kg d)]; animals in groups III -V were given intragastric administration of isoalantolactone at concentrations of 1, 10, 100 mg/(kg d), respectively. Daily administration of cyclophosphamide and isoalantolactone was carried out from day 1 to day 10. Animals were observed for the development of ascite tumours. At the termination of the experiment all animals were sacrifi ced, and tumours, thymuses, and spleens were dissected and weighed. Tumour inhibition was calculated using the following formula: tumour inhibition (in % of control) = (C−T)/C · 100%, where T and C are the mean tumour weights of treated and control mice, respectively. Spleen indexes were calculated by the formula: spleen index = mean spleen weight (mg)/mean body weight (g) · 100%.
Statistical analysis
Statistical analysis was performed by ANOVA with Bonferroni for multiple comparisons. The data are given as mean  SD. A value of P > 0.05 was considered statistically signifi cant.
